World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
12705
World Ranking
14319
National Ranking
6034

Overview

Michael S. Glickman is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans several intersecting fields including Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these main disciplines, their work often focuses on Immunology, Infectious Diseases, Molecular Biology, Epidemiology, and Molecular Medicine.

The scientist has contributed to research topics such as Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria, Immune cells in cancer, Mycobacterium research and diagnosis, Immune responses and vaccinations, Bacterial Genetics and Biotechnology, and Immune Cell Function and Interaction.

Michael S. Glickman has published extensively in several venues. Frequent publication sources include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • eLife
  • Nature Communications
  • mBio
  • Nature Medicine

Their recent papers reflect a focus on infectious and immune-related diseases, as well as cancer immunology. Notable recent publications include:

  • "Determinants of COVID-19 disease severity in patients with cancer," 2020, Nature Medicine
  • "Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child," 2021, Nature Medicine
  • "Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling," 2020, Proceedings of the National Academy of Sciences
  • "Integrated sensing of host stresses by inhibition of a cytoplasmic two-component system controls M. tuberculosis acute lung infection," 2021, eLife
  • "Determinants of Severity in Cancer Patients with COVID-19 Illness," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Collaboration plays a significant role in their research, with frequent coauthors including John A. Buglino, Pierre Dupuy, Gil Redelman-Sidi, James Bean, and Allison Fay. These partnerships reflect a strong engagement with experts in related fields and interdisciplinary approaches.

Best Publications

  • TOX is a critical regulator of tumour-specific T cell differentiation

    Andrew C Scott;Andrew C Scott;Friederike Dündar;Paul Zumbo;Smita S Chandran

  • A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.

    Michael S Glickman;Jeffery S Cox;William R Jacobs

  • The mechanism of action of BCG therapy for bladder cancer—a current perspective

    Gil Redelman-Sidi;Michael S. Glickman;Bernard H. Bochner

  • Determinants of COVID-19 disease severity in patients with cancer.

    Elizabeth V. Robilotti;Elizabeth V. Robilotti;N. Esther Babady;Peter A. Mead;Peter A. Mead;Thierry Rolling

  • Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline

    Michael S. Glickman;William R. Jacobs

  • Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host Cells

    Kamalakannan Velmurugan;Bing Chen;Jessica L Miller;Sharon Azogue

  • Antibody-catalyzed degradation of cocaine

    Donald W. Landry;Kang Zhao;Ginger X. Q. Yang;Michael Glickman

  • Bacterial DNA repair by non-homologous end joining.

    Stewart Shuman;Michael S Glickman

  • Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule

    Vivek Rao;Nagatoshi Fujiwara;Steven A. Porcelli;Michael S. Glickman

  • A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo

    Alena M. Gallegos;Alena M. Gallegos;Jeroen W. J. van Heijst;Miriam Samstein;Xiaodi Su

  • CarD Is an Essential Regulator of rRNA Transcription Required for Mycobacterium tuberculosis Persistence

    Christina L. Stallings;Nicolas C. Stephanou;Linda Chu;Ann Hochschild

  • Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C.

    Chunling Gong;Paola Bongiorno;Paola Bongiorno;Alexandra Martins;Alexandra Martins;Nicolas C Stephanou;Nicolas C Stephanou

  • Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection.

    Alena M. Gallegos;Eric G. Pamer;Michael S. Glickman

  • Trans -cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis –induced inflammation and virulence

    Vivek Rao;Feng Gao;Bing Chen;William R. Jacobs

  • Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis

    Chih Chin Huang;Clare V. Smith;Michael S. Glickman;William R. Jacobs

  • Converting Cancer Therapies into Cures: Lessons from Infectious Diseases

    Michael S. Glickman;Charles L. Sawyers;Charles L. Sawyers

  • Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming

    Miriam Samstein;Heidi A Schreiber;Ingrid M Leiner;Bože Sušac

  • The Mycobacterium tuberculosis cmaA2 Gene Encodes a Mycolic Acid trans-Cyclopropane Synthetase

    Michael S. Glickman;Sean M. Cahill;William R. Jacobs

  • Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.

    Matthew F. Wipperman;Matthew F. Wipperman;Daniel W. Fitzgerald;Marc Antoine Jean Juste;Ying Taur

  • Biochemical and Genetic Analysis of the Four DNA Ligases of Mycobacteria

    Chunling Gong;Alexandra Martins;Paola Bongiorno;Michael Glickman

Frequent Co-Authors

Stewart Shuman
Stewart Shuman Memorial Sloan Kettering Cancer Center
Eric G. Pamer
Eric G. Pamer Memorial Sloan Kettering Cancer Center
William R. Jacobs
William R. Jacobs Albert Einstein College of Medicine
Jeffrey Aubé
Jeffrey Aubé University of North Carolina at Chapel Hill
Ying Taur
Ying Taur Memorial Sloan Kettering Cancer Center
Jeffrey R. Johnson
Jeffrey R. Johnson Icahn School of Medicine at Mount Sinai
Seth A. Darst
Seth A. Darst Rockefeller University
Tobias M. Hohl
Tobias M. Hohl Memorial Sloan Kettering Cancer Center
Kent A. Sepkowitz
Kent A. Sepkowitz Memorial Sloan Kettering Cancer Center
Nevan J. Krogan
Nevan J. Krogan University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Michael S. Glickman

Trending Scientists

Recently Published Articles